The Exogenously Driven Disruption of Bioprocessing by Industry 4.0
Posted on October 14, 2022
Christos Varsakelis, Team Lead Artificial Intelligence/Machine Learning, The Janssen Pharmaceutical Companies of Johnson & Johnson
Abstract Industry 4.0 comes with an impressive collection of assets and capabilities. However, although the degree of applicability in Bioprocessing is high, the origin of these technological innovations is exogenous. This is not without implications and in this talk we are concerned with their iden...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy















